This segment focuses on providing comprehensive clinical trial services for the biopharmaceutical and medical device industries. Tigermed offers full-service clinical trial management, including study design, site selection, patient recruitment, data management, biostatistics, and medical monitoring. Research and development activities include protocol development, clinical trial execution, and regulatory submissions. Technologies and methodologies employed encompass advanced data analytics, electronic data capture (EDC) systems, and risk-based monitoring. Therapeutic areas covered span a wide range, including oncology, cardiology, neurology, and infectious diseases. The patient impact is significant, as these trials contribute to the development of new and improved therapies. Tigermed's market positioning is strong, particularly in China, with a growing global presence. Future opportunities lie in expanding into emerging markets and leveraging AI and machine learning for enhanced trial efficiency. Regulatory and clinical aspects are central to this segment, ensuring compliance with global standards. Partnerships and collaborations with pharmaceutical companies and research institutions are key to success.

This segment encompasses a broad range of services supporting clinical trials and drug development. Key activities include bioanalytical testing, central laboratory services, medical imaging, and regulatory consulting. Research and development efforts focus on developing new laboratory assays and improving the accuracy and efficiency of testing procedures. Technologies and methodologies include advanced analytical instruments, such as mass spectrometers, and sophisticated data analysis techniques. Therapeutic areas served are diverse, including oncology, immunology, and infectious diseases. The patient impact is reflected in the accurate and timely assessment of drug efficacy and safety. Tigermed's market position is strengthened by its comprehensive service offerings and strong relationships with pharmaceutical companies. Future opportunities include expanding laboratory capacity and developing new diagnostic services. Regulatory and clinical aspects are critical, ensuring compliance with Good Laboratory Practice (GLP) and other relevant regulations. Partnerships with medical device companies and pharmaceutical companies are essential for providing integrated solutions.

This segment provides specialized services for medical device and in vitro diagnostics (IVD) companies. Tigermed offers services including medical device testing, regulatory submission support, clinical evaluation and trials, and GMP certification assistance. Research and development activities focus on developing new testing methodologies and improving the efficiency of clinical trials for medical devices. Technologies and methodologies include advanced testing equipment and rigorous clinical trial protocols. Therapeutic areas include a wide range of medical specialties, such as cardiology, orthopedics, and diagnostics. The patient impact is significant, as these services contribute to the development and approval of safe and effective medical devices. Tigermed's market positioning is enhanced by its expertise in navigating the complex regulatory landscape for medical devices. Future opportunities include expanding into new medical device categories and providing services for innovative technologies. Regulatory and clinical aspects are paramount, ensuring compliance with FDA, EU MDR, and other relevant regulations. Partnerships with medical device manufacturers and regulatory agencies are crucial for success.